arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Alpha Cognition Inc.

ACOG
$9.14 ▲ +0.77 (+9.20%) at close
Healthcare ·Biological Products, (No Diagnostic Substances) ·USBiological Products, (No Diagnostic Substances)
4 Visible periods
24 Metrics
Peer-ranked Benchmarks
Price Chart
16
Health
Poor
Bearish
auto_awesome

Analytical Summary

Alpha Cognition Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $161.6M
Dividend Yield
Revenue Growth
Op. Margin -221.7%
ROIC -28.6%
FCF / Share $-1.17
Trailing P/E
Price / Book 3.2x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

4-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$-20.67M
↓ -41.2%
FCF / Share Free cash flow per share
$-1.17
↓ -8.9%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
1
Returns
22
Financial Health
2
Cash Quality
66

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 4 years · 17 quarters